U.S. Water Utilities Stock News

NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Madrigal Pharmaceuticals (MDGL) Stock Valuation As Rezdiffra Data Plans And Mixed Analyst Updates Shape Expectations

Conference spotlight and mixed analyst views put Madrigal Pharmaceuticals (MDGL) in focus Madrigal Pharmaceuticals (MDGL) is back on investors’ radar after recent analyst commentary on its MASH treatment Rezdiffra and plans to showcase fresh clinical and real world data at the upcoming EASL Congress 2026. The stock is also drawing attention ahead of Madrigal’s presentation at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, where management is expected to discuss...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

JetBlue (JBLU) Stock Valuation Check After Recent Rebound And Mixed Long Term Returns

JetBlue Airways stock: recent performance snapshot JetBlue Airways (JBLU) has recently drawn investor attention after a period of mixed financial metrics and stock returns, with the shares moving over the past month and past 3 months on shifting expectations. Over the past month, the stock shows a 9.39% gain, with a 17.61% rise over the past 3 months and a 12.08% total return over the past year. These moves sit alongside a weaker 3 year and 5 year record, where total returns declined 37.84%...
NYSE:MOS
NYSE:MOSChemicals

Mosaic’s Capex Cut Amid Margin Pressure Might Change The Case For Investing In MOS

In the recent past, Mosaic reported first-quarter 2026 results showing higher year-over-year sales but adjusted earnings that fell short of estimates as input costs surged and gross margins in key segments compressed. Management responded by trimming 2026 capital expenditure guidance by US$250,000,000 while keeping its potash production outlook and main annual financial targets intact, highlighting a focus on cash discipline amid operational pressure. With Mosaic cutting its capital...
NasdaqGS:CPB
NasdaqGS:CPBFood

Why Campbell's (CPB) Is Up 5.2% After Freezing Payouts Amid Mixed Q3 Results And What's Next

In early June 2026, Campbell’s reported third-quarter results showing sales slipping to US$2,366 million from US$2,475 million a year earlier, while net income rose to US$124 million and diluted EPS from continuing operations increased to US$0.41 from US$0.22. At the same time, management froze the dividend, halted buybacks, and doubled down on cost savings and innovation launches to shore up profitability and protect its investment-grade credit rating. Now we’ll examine how these weaker...
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

Do Five9’s (FIVN) ESOP Shelf Plans Hint At A Shift In Its AI Licensing Strategy?

In early June 2026, Five9 filed a shelf registration for up to US$70.934 million, covering 2,900,000 shares of common stock in an ESOP-related offering. At the same time, investor focus shifted toward how new Anthropic AI models might affect traditional per-seat SaaS licensing models used by providers like Five9. We’ll examine how concerns about Anthropic’s new AI models and evolving SaaS licensing expectations may influence Five9’s broader investment narrative. Invest in the nuclear...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Stock After Buyback Expansion And New Funding Deal Is The Valuation Gap Still There

Dave (DAVE) has drawn fresh attention after expanding its share repurchase authorization to US$300 million and unveiling a new funding arrangement for its ExtraCash receivables with Coastal Community Bank, reshaping its capital and liquidity profile. See our latest analysis for Dave. The share price is now US$286.78 after a 7 day share price return of 11.05% and a 90 day share price return of 35.26%, while the 1 year total shareholder return of 37.72% sits against a five year total...
NYSE:PATH
NYSE:PATHSoftware

UiPath Maestro Win At One New Zealand Highlights Undervalued PATH Potential

UiPath (NYSE:PATH) reported that its Maestro platform has been used by One New Zealand Limited to revamp a complex telecom workflow. The deployment enabled near real-time mobile provisioning while keeping existing legacy systems in place. One New Zealand is now extending Maestro to additional mission critical processes after the initial rollout. For investors watching UiPath, this case highlights the company’s core pitch as an orchestration layer for automation and AI agents in large,...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Regulatory Rebuke Tests JD.com Promotions And Long Term Brand Trust

Chinese regulators have reprimanded JD.com and other large e commerce platforms over misleading advertising and irregular discount practices during the 618 shopping festival. Authorities ordered immediate fixes to subsidy campaigns, price disclosures, and consumer protection measures tied to the event. The action signals closer scrutiny of how NasdaqGS:JD structures and markets its major sales promotions. For JD.com, trading at $28.56, the regulatory move comes after a period of weaker...
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (GMED) Stock After 36% One-Year Gain Is There Still Upside?

Wondering whether Globus Medical at around US$80.39 still offers value or if the easy money has already been made? This article breaks down what the current price might be implying about the stock. Globus Medical has returned 0.5% over the past week and 4.9% over the past month, while year to date the stock is down 7.9% and up 36.5% over the past year. Recent coverage has focused on how Globus Medical fits into broader interest in medical technology and healthcare equipment, as investors...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

How OpenText’s €105M Ireland Bet On Agentic AI And Sovereign Cloud At Open Text (OTEX) Has Changed Its Investment Story

On 12 June 2026, OpenText announced a €105 million investment that will create 400 new jobs in Cork and Galway, expanding its agentic AI, cybersecurity, sovereign cloud, and digital operations capabilities for EMEA clients. This move doubles OpenText’s commitment to Ireland and positions its Irish operations as a core hub for trusted enterprise AI and sovereign cloud services in highly regulated sectors. Next, we’ll examine how this expanded Ireland footprint in agentic AI and sovereign...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk’s CagriSema Breakthrough Expands Growth Story Beyond Diabetes and Obesity

Novo Nordisk (NYSE:NVO) reported positive Phase 3 results from its REIMAGINE program for CagriSema, a combination therapy for type 2 diabetes. The trial data showed substantial reductions in HbA1c and body weight in treated patients. Company leadership is outlining plans to build on this platform by expanding into longevity and aesthetics beyond its core diabetes and obesity focus. Novo Nordisk, best known for its diabetes and obesity drugs, is now signaling a broader healthcare vision that...
NYSE:CRGY
NYSE:CRGYOil and Gas

How Investors May Respond To Crescent Energy (CRGY) As Middle East Tensions Jolt Oil Markets

In recent days, Crescent Energy has been affected by heightened geopolitical tensions in the Middle East, including U.S. military actions involving Iran, supply disruptions, and partial closure of the Strait of Hormuz that have driven sharp swings in oil prices. These events have emphasized how sensitive Crescent Energy’s U.S. shale business is to geopolitical risk and sudden shifts in global oil supply dynamics. We’ll now assess how heightened Middle East supply risks, and the resulting oil...
NYSE:BE
NYSE:BEElectrical

How Conflicting Wyoming AI Power Reports Could Reshape Bloom Energy’s (BE) Project Concentration Narrative

In recent days, Bloom Energy has been at the center of conflicting reports about a major AI data center project in Cheyenne, Wyoming, after developer Crusoe Energy paused work while utility Black Hills said the multi‑gigawatt campus, including Bloom’s fuel cells, remains on track with a different large‑load customer for service by early 2028. This episode has highlighted how heavily Bloom’s growth story is tied to a small number of very large AI power contracts, sharpening investor focus on...
NYSE:DG
NYSE:DGConsumer Retailing

Dollar General (DG) Stock After Q1 Beat And Raised Guidance Is The Rebound Still Undervalued

Dollar General (DG) is back in focus after first quarter sales and earnings surpassed the prior year, prompting higher full year guidance and drawing attention to delivery growth, an expanding customer mix, and a reaffirmed dividend. See our latest analysis for Dollar General. The Q1 beat and raised guidance have coincided with a sharp near term rebound, with a 7 day share price return of 10.70% and 30 day share price return of 12.83%. However, the year to date share price return is still...
NYSE:ULS
NYSE:ULSProfessional Services

Does Stronger Q1 Results And Insider Activity Shift The Bull Case For UL Solutions (ULS)?

UL Solutions recently delivered strong first-quarter results, with revenues growing 7.5% year over year and surpassing analyst expectations in its testing, inspection and certification business. At the same time, the company’s senior leadership has been active in investor conferences and insider share sales, offering additional clues about management’s confidence and capital priorities. We’ll now examine how UL Solutions’ stronger-than-expected quarterly performance may influence the...
NYSE:EGP
NYSE:EGPIndustrial REITs

Is EastGroup’s Sunbelt Demand Update Quietly Reframing the Core Thesis for EGP’s Industrial Portfolio?

EastGroup Properties, Inc. previously announced that it would hold its Second Quarter 2026 earnings conference call and webcast on July 23, 2026, where senior management planned to discuss second quarter results, current operations, and the 2026 earnings outlook, with supporting materials released after market close on July 22, 2026. Alongside this, management highlighted resilient demand for its Sunbelt logistics and distribution properties, underpinned by limited new supply, healthy...
NYSE:AGO
NYSE:AGOInsurance

The Bull Case For Assured Guaranty (AGO) Could Change Following Analyst Upgrade And Capital Strength Signals

In May 2026, UBS analyst Brian Meredith upgraded Assured Guaranty Ltd. (NYSE: AGO) to Buy, citing its leadership in the credit protection market, resilient earnings profile, and strong cash generation, while Roth Capital highlighted that the company remains well-capitalized following better-than-expected first-quarter results. A key insight from these developments is that analysts see Assured Guaranty’s balance sheet strength as supporting ongoing share repurchases alongside its core...
NYSE:UBER
NYSE:UBERTransportation

Uber (UBER) Stock And Robotaxi Push In Europe A Fresh Look At Valuation And Growth Potential

Uber Technologies (UBER) is pushing deeper into autonomous ride-hailing, forming new robotaxi partnerships in Munich and Madrid that integrate self-driving fleets directly into its existing mobility platform across major European cities. See our latest analysis for Uber Technologies. Despite the robotaxi headlines and new partnerships in Europe, Uber’s recent momentum has been weak, with the share price down 7.83% over the past month and the year to date share price return down 16.91%, even...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Profitable AI Stocks One Connects Data One Cools Racks One Commands Governments

AI is no longer just a buzzword; it is starting to show up in real revenue and profit lines at a time when investors are juggling inflation risks, energy price swings and shifting interest rate expectations across major central banks. With bond markets and global growth indicators sending mixed signals, many investors are looking for companies that are not only spending on AI, but already converting that spend into earnings. This article highlights three stocks from the Profitable AI Stocks...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

Can ACI Worldwide’s (ACIW) African Orchestration Push Redefine Its Competitive Edge In Payments?

ACI Worldwide recently announced that South Africa-based Kwik Payments has gone live on the ACI Payments Orchestration Platform, enabling faster merchant onboarding, multi-channel payment routing, and AI-driven fraud detection across South Africa and the wider African market. This rollout highlights how ACI’s orchestration technology can simplify complex checkouts, support emerging payment methods, and materially cut manual reconciliation work for merchants. We’ll now examine how ACI’s...
NYSE:ROL
NYSE:ROLCommercial Services

Rollins (ROL) Stock Valuation Checked Against Popular Overvaluation Narrative

Rollins stock performance context Rollins (ROL) has been on investors’ radar after a period where the stock is down about 11% over the past month and 14% over the past 3 months, despite steady pest control operations. See our latest analysis for Rollins. At a share price of $47.19, Rollins has seen its recent momentum fade, with the 30 day share price return down 10.66% and year to date share price return down 20.03%. However, the 5 year total shareholder return of 52.16% still reflects solid...
NasdaqGS:APP
NasdaqGS:APPSoftware

AppLovin (APP) Stock After Recent AI Competition And Macro Jitters Is The 20.5% Undervaluation Story Justified

Recent swings in AppLovin (APP) have been tied to fresh competition from Anthropic’s new AI models, a sector wide pullback in high growth software stocks, and broader macro concerns linked to geopolitical events. See our latest analysis for AppLovin. Despite the recent pullback, including a 7 day share price return that is down 10.85%, AppLovin’s 30 day share price return of 9.53% and 90 day share price return of 8.31% sit against a very strong 1 year total shareholder return of 36.29% and an...
NYSEAM:TMP
NYSEAM:TMPBanks

Tompkins Financial (TMP) Stock Up Strongly Is The Current Valuation Still Attractive

If you are wondering whether Tompkins Financial at around US$92 is priced attractively or already baking in a lot of optimism, the valuation picture is the key place to focus next. The stock has shown strong recent share price performance, with returns of 5.3% over 7 days, 11.2% over 30 days, 26.9% year to date, 56.6% over 1 year, 73.4% over 3 years and 40.9% over 5 years. Recent commentary around Tompkins Financial has centered on how regional banks are being reassessed by investors, with...
NYSE:GEL
NYSE:GELOil and Gas

Genesis Energy (GEL) Stock Valuation After Balance Sheet Repair And Offshore Project Ramp Up

Conference spotlight: why Genesis Energy is on investors’ radar Genesis Energy (GEL) is stepping in front of credit and energy investors this week, presenting at Bank of America and RBC conferences as its balance sheet work and offshore growth projects attract fresh attention. See our latest analysis for Genesis Energy. Despite balance sheet progress and the ramp up of the Shenandoah and Salamanca offshore projects, Genesis Energy’s 90 day share price return is down 14.76%, while its 5 year...